Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_4
1
14%
Ph phase_2
1
14%
Ph early_phase_1
1
14%
Ph not_applicable
3
43%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Withdrawn1
Recruiting1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A3 (42.9%)

Trials by Status

withdrawn114%
recruiting114%
active_not_recruiting114%
unknown114%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7